Prediction of the response to citalopram and reboxetine in post-stroke depressed patients: the reasons of the enrollment of patients without cognitive impairment
β Scribed by Liborio Rampello; Alessandro Alvano
- Publisher
- Springer
- Year
- 2004
- Tongue
- English
- Weight
- 31 KB
- Volume
- 175
- Category
- Article
- ISSN
- 0033-3158
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Depression is the most common psychiatric disorder among the elderly and in old age may interact with emotional and cognitive functioning. Depression in old age has been shown to be associated with degenerative changes in the brain. It is, therefore, important that in this patient population antidep
## Abstract ## Objective The Regenerate pilot study explored whether a 10βweek, communityβbased progressive resistance training (PRT) program could reduce depressive symptoms in depressed chronic stroke survivors. ## Methods Participants were screened for depressive status using the PHQβ9 and co
## Abstract ## Background Mild cognitive impairment (MCI) is often a prodromal of dementia and depressive symptoms have been suggested as risk factor for dementing disorders. We evaluated the possible impact of depressive symptoms on the rate of progression to dementia in MCI patients after a 3.5β
## Abstract The reactivity of peripheral blood lymphocytes from patients with advanced malignancy was assessed by mitogenβinduced stimulation of protein synthesis as measured by ^3^Hβleucine incorporation. It was confirmed that the lymphocyte response of patients was depressed. Furthermore, the lym